Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2024 for Gain Therapeutics, Inc., €46k.
Filing timeline
BuySaleKhalid Islam
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Khalid Islam: trading record in brief
Khalid Islam is a declared insider at 4 companies (board member); the most frequent names are Fennec Pharmaceuticals Inc., Immunomedics Inc and Gain Therapeutics, Inc. We count 10 filings; the first trade dates from 2 April 2018 and the latest from 9 August 2024.
Every open-market trade on record is a purchase: 1 purchase worth €46k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 share grants and 4 option exercises. Since January 2024: 1 purchase and no sales on the market.
The latest filing, published on 12 August 2024, reports an open-market purchase of €46k in Gain Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Khalid Islam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
50,000 shares@ US$0.9988100.0% of flowCommon StockSEC:0001493152-24-031377:0
Canonical exit: 7 Nov 2024 (T+90)
133,333 shares@ US$2.31100.0% of flowCommon SharesSEC:0001415889-23-015193:0
4,392 sharesCommon StockSEC:0001567619-22-008012:0
3 of 3 declarations
